KBIO LABS stock price
KRX:038530 · KOSDAQ · Healthcare · sector #21KBIO LABS's chart data is dated 2026-11-06. Recorded technical signals: MACD bullish cross. The display ticker is 038530.
- KBIO LABS's 52-week range runs from ₩2,540 to ₩13,750. The latest close of ₩2,605 is near the bottom of that range (−81.1% from the high).
- By close, the price moved −32.9% over 1 month, −50.0% over 3 months, −66.4% over 6 months, −60.1% over 1 year.
- Technical signals currently flagged: MACD bullish cross.
KBIO LABS Talk · Newest
For account, order or payment questions, please send a 1:1 inquiry · 1:1 inquiry →
Loading Talk…
KBIO LABS last closed at ₩2,605 (-7.79%) on 2026-11-06. Signals today: MACD bullish cross. Listed on KOSDAQ. Trailing 12 months PER is -1.0×. Its overall grade ranks 199 of 350 stocks in Healthcare.
KBIO LABS overview
KBIO LABS is listed on KOSDAQ and classified in the Healthcare sector. Its market capitalization is about KRW 14.63B. PER -1.0× and PBR 0.37× on the latest published figures. Trading records run from 2025-10-30 to 2026-11-06, a full year or more.
Revenue grew from KRW 27.33B in 2023 to KRW 87.31B in 2025 (+220%).
Position within its sector
Among 350 stocks in Healthcare, KBIO LABS ranks No. 199 on the overall grade (B-), within the top 57% of its sector.
By factor, valuation (A-, top 24%) and financial quality (B, top 50%) stand out the most, while price momentum (C, top 79%) is the weakest of the 5.
Grades are relative positions within the same sector, shown for reference only.
About this company
Quantus's relationship data lists competitors: LG Chem, ABL Bio, SK Biopharmaceuticals; customers: Samsung Biologics, Celltrion; suppliers: Samsung SDS, KT and 1 more.
By revenue it ranks No. 147 of the 318 companies with revenue data in Healthcare, with 0.1% of the sector's total revenue.
The sector is fragmented: its top three companies hold 16.2% of revenue.
Reported results
Position in sector
Healthcare · Overall B- · 199/350
Valuation grade A-
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- Samsung BiologicsCustomer
- CelltrionCustomer
- Samsung SDSSupplier
About KBIO LABS
- What technical signals does KBIO LABS (038530) have?
- KBIO LABS current technical signals: MACD bullish cross.
- What published figures are available for KBIO LABS?
- Market cap: KRW 14.63B. Trailing 12 months PER: -1.0×. Latest quarter PBR: 0.37×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-11-06 dataset
Turn what you saw on this name into a strategy
Ask Q about KBIO LABS, or open the plan table on the main site.
Ask Q about KBIO LABS.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.